Masimo Goes Public, Building On Recent Pulse Oximetry Market Share Gains
This article was originally published in The Gray Sheet
Pulse oximetry device maker Masimo's successful initial public stock offering Aug. 8 reflects in part the company's ability to capitalize on a doubling of its market share over the past two years
You may also be interested in...
Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International
Masimo believes its $420 mil. legal victory over Tyco will spur large manufacturers and GPOs to gradually alter their business practices, resulting in long-term cost savings for hospitals
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.